Symbol="BLTE"
AssetType="Common Stock"
Name="Belite Bio Inc ADR"
Description="Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, is engaged in the research and development of novel therapies targeting age-related atrophic macular degeneration and autosomal recessive stargardt diseases. The company is headquartered in San Diego, California."
CIK="1889109"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, CA"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="365921000"
EBITDA="-18576500"
PERatio="None"
PEGRatio="None"
BookValue="1.412"
DividendPerShare="0"
DividendYield="0"
EPS="-0.74"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.256"
ReturnOnEquityTTM="-0.712"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.74"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="56"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="15.48"
EVToRevenue="-"
EVToEBITDA="-91.18"
Beta="None"
num_52WeekHigh="44.63"
num_52WeekLow="11"
num_50DayMovingAverage="18.27"
num_200DayMovingAverage="27.03"
SharesOutstanding="27226300"
DividendDate="None"
ExDividendDate="None"
symbol="BLTE"
open="12.66"
high="13.49"
low="12.66"
price="13.44"
volume="14139.00"
latest_trading_day="2023-07-14"
previous_close="12.94"
change="0.50"
change_percent="3.8640%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="80"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="20"
Volume_recent_avg="27008"
Change_recent_avg="-0.19"
Delta_recent_avg="1.32"
Variance_recent_avg="0.66"
Change_ratio_recent_avg="-0.98"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="20"
Aroon_momentum_negative="80"
image_negative_thumbnail_id_1="126"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0050.jpeg"
image_negative_thumbnail_id_2="118"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0058.jpeg"
image_neutral_thumbnail_id_1="583"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_neutral_thumbnail_id_2="525"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_positive_thumbnail_id_1="987"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0149.jpeg"
image_positive_thumbnail_id_2="959"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0121.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
